| Literature DB >> 33530230 |
Rafał Januszek1,2,3, Kamil Bujak4,5, Mariusz Gąsior4,5, Jacek Legutko6, Stanisław Bartuś1,2,7.
Abstract
ABSTRACT: The relationship regarding time of percutaneous coronary intervention (PCI) and clinical outcomes in patients with acute myocardial infarction (AMI) treated within the left main coronary artery (LMCA) is less investigated compared to the overall group of patients with AMI.Therefore, we aimed to assess the relationship between time of PCI (day- vs night-time) and overall mortality rate in patients treated due to AMI within the LMCA.This cross-sectional study included 443,805 AMI patients hospitalized between 2006 and 2018 enrolled in the Polish Registry of Acute Coronary Syndromes. We extracted 5,404 patients treated within the LMCA. The number of patients were treated during daytime hours (7:00 am-10:59 pm) was 2809 while 473 patients underwent treatment during night-time hours (11:00 pm-6:59 am). Differences in cardiac mortality rates between night- and day-hours among patients treated with PCI during the follow-up period were assessed via the Kaplan-Meier method.The 30-day (20.3% vs 14.9%, P = .003) and 12-month (31.7% vs 26.2%, P = .001) overall mortality rates were significantly greater among patients treated during night-time, which was confirmed by comparison using Kaplan-Maier survival curves (P = .001). The time of PCI was not found among predictors of survival in multiple regression analysis (hazard ratio: 1.22; 95% confidence interval: 0.96-1.55, P = .099).Patients treated during night-time in comparison to the day-time are related to higher in-hospital, 30-day and 12-month mortality. This is probably largely a consequence that the night-time, in comparison to the day-time, of treatment of patients with AMI with PCI within the LMCA is and indicator of higher comorbidity and clinical acuity of patients undergoing therapy. Therefore, the night-time was not found to be an independent predictor of greater mortality rate during the 12-months follow-up period.Entities:
Mesh:
Year: 2021 PMID: 33530230 PMCID: PMC7850639 DOI: 10.1097/MD.0000000000024360
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Flow chart of patients throughout following stages of analysis.
Clinical characteristics in patients with acute myocardial infarction and treated with percutaneous coronary intervention within main-left coronary artery according to time of procedure (day vs night).
| Selected indices | D | Night | |
| Gender, males | 67.64 | 67.02 | .79 |
| Age, yr | 70.79 (61.52–79.73) | 69.73 (60.8–78.82) | .13 |
| Type of myocardial infarction | |||
| STEMI | 67.21 | 49.89 | < .001 |
| NSTEMI | 32.79 | 50.11 | |
| Systolic blood pressure, mm Hg | 130.0 (120.0–150.0) | 130.0 (115.0–150.0) | .24 |
| Diastolic blood pressure, mm Hg | 80.0 (70.0–90.0) | 80.0 (70.0–90.0) | .75 |
| Killip–Kimball class grade | |||
| I | 71.80 | 67.65 | .014 |
| II | 21.00 | 21.35 | |
| III | 7.19 | 10.99 | |
| Door-to-balloon time, min | |||
| - Overall group | 112.0 (47.0–501.0) | 53.0 (35.0–108.0) | < .001 |
| - STEMI | 52 (31–100) | 45 (30–73) | .004 |
| - NSTEMI | 201 (70–915) | 71.5 (40–177) | < .001 |
| Prior percutaneous coronary intervention | 17.90 | 13.14 | .011 |
| Prior myocardial infarction | 23.43 | 19.07 | .037 |
| Prior cerebral stroke | 4.93 | 5.83 | .44 |
| Peripheral arterial disease | 9.33 | 8.76 | .71 |
| Diabetes | 29.09 | 29.81 | .75 |
| Prior or present smoking | 57.78 | 57.21 | .82 |
Data are presented as percentages or median (min, max), for age (lower-upper interquartile range).
NSTEMI = non-ST segment elevation myocardial infarction, STEMI = ST-segment elevation myocardial infarction.
Procedural indices and left ventricle ejection fraction in patients with acute myocardial infarction and treated with percutaneous coronary intervention within main-left coronary artery according to time of procedure (day vs night).
| Selected indices | D | Night | |
| Left ventricle ejection fraction | 45.0 (35.0–50.0) | 45.0 (35.0–52.0) | .69 |
| Infarct related artery within LMCA | 77.25 | 77.17 | .97 |
| PCI other than LMCA | 34.78 | 33.83 | .69 |
| Intra-aortic balloon counterpulsation | 4.45 | 5.50 | .31 |
| In-hospital mode CABG | 1.67 | 1.48 | .76 |
| PCI within LMCA volume per 1 CathLab/yr | 3.92 (2.67–5.36) | 3.92 (2.5–6.2) | .85 |
| TIMI grade flow before PCI | |||
| 0 | 20.76 | 27.70 | .003 |
| 1 | 20.23 | 20.30 | |
| 2 | 23.01 | 22.62 | |
| 3 | 36.00 | 29.39 | |
| TIMI grade flow after PCI | |||
| 0 | 2.76 | 3.46 | .35 |
| 1 | 1.23 | 2.16 | |
| 2 | 4.28 | 4.32 | |
| 3 | 91.73 | 90.06 | |
Data are presented as percentages or median (min, max).
CABG = coronary artery bypass grafting, CathLab = catheterization laboratory, LMCA = left main coronary artery, PCI = percutaneous coronary intervention, TIMI = thrombolysis in myocardial infarction.
In-hospital and long-term clinical outcomes in patients with acute myocardial infarction and treated with percutaneous coronary intervention within main-left coronary artery according to time of procedure (day vs night).
| Follow-up events | D | Night | |
| In-hospital outcomes | |||
| Cardiogenic shock | 4.89 | 10.19 | < .001 |
| In-hospital cardiac arrest | 7.31 | 10.59 | .014 |
| Major bleedings | 1.82 | 1.27 | .4 |
| In-hospital re-infarction | 1.11 | 0.00 | .022 |
| Target vessel revascularization | 1.18 | 1.27 | .86 |
| In-hospital mortality | 10.57 | 14.38 | .015 |
| Long-term outcomes | |||
| 30-d mortality | 14.88 | 20.30 | .003 |
| 12-mo mortality | 26.20 | 31.70 | .001∗ |
Data are presented as percentages.
log-rank.
Figure 2Kaplan–Meier overall mortality survival curves according to day- and night-time of PCI.
Relationship of selected indices with 12-month mortality – univariate Cox regression analysis.
| Selected predictor | HR | 95% CI | |
| PCI LMCA night vs d | 1.31 | 1.1–1.57 | .003 |
| Intra-aortic balloon counterpulsation | 2.86 | 2.27–3.59 | < .001 |
| Left ventricle ejection fraction, % | 0.94 | 0.93–0.95 | < .001 |
| Systolic blood pressure, mm Hg | 0.99 | 0.98–0.99 | < .001 |
| Diastolic blood pressure, mm Hg | 0.98 | 0.98–0.99 | < .001 |
| Gender, males | 1.01 | 0.88–1.17 | .88 |
| Prior myocardial infarction | 1.38 | 1.18–1.6 | < .001 |
| Prior percutaneous coronary intervention | 1.19 | 1.00–1.41 | .047 |
| Prior cerebral stroke | 1.64 | 1.25–2.148 | < .001 |
| Peripheral arterial disease | 1.68 | 1.36–2.07 | < .001 |
| Age, yr | 1.04 | 1.03–1.05 | < .001 |
| Prior or present smoking | 0.89 | 0.78–1.03 | .11 |
| Diabetes | 1.22 | 1.05–1.4 | .007 |
| Killip–Kimball class grade III vs I and II | 2.78 | 2.31–3.35 | < .001 |
| PCI of artery other than LMCA | 1.14 | 0.99–1.34 | .06 |
| Door-to-balloon time, min. | 1.0 | 1.0–1.0 | .86 |
| Type of myocardial infarction STEMI vs NSTEMI | 1.04 | 0.9–1.2 | .6 |
| TIMI grade flow before PCI 0–1 vs 2–3 | 1.23 | 1.07–1.41 | .002 |
| PCI within LMCA volume per 1 CathLab/yr | 1.0 | 0.97–1.03 | .98 |
CathLab = catheterization laboratory, LMCA = left-main coronary artery, NSTEMI = non-ST segment elevation myocardial infarction, PCI = percutaneous coronary intervention, STEMI = ST-segment elevation myocardial infarction, TIMI = thrombolysis in myocardial infarction.
Figure 3Predictors of 12-month overall mortality in patients with acute myocardial infarction and treated with percutaneous coronary intervention within the left main coronary artery.